MAP2K7 and neoplasm: This drug not only directly suppresses tumor cells proliferation by blocking RAF/MEK/ERK and JAK/STAT signaling pathways, but also inhibits tumor angiogenesis by targeting VEGFRs, PDGFR-β, c-Kit, FLT3, RET (33, 34).